Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • IL Receptor
    (6)
  • NF-κB
    (5)
  • NO Synthase
    (4)
  • TLR
    (4)
  • TNF
    (4)
  • COX
    (3)
  • JNK
    (3)
  • MAPK
    (3)
  • Prostaglandin Receptor
    (3)
  • Others
    (21)
Filter
Search Result
Results for "

microglia

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    57
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    4
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • Natural Products
    19
    TargetMol | Natural_Products
  • Recombinant Protein
    12
    TargetMol | Recombinant_Protein
  • Disease Modeling
    2
    TargetMol | Disease_Modeling_Products
D-GsMTx4 TFA
T37697L
D-GsMTx4 TFA, a selective spider venom peptide, is a TRPC1/6 and Piezo2 inhibitor that inhibits cation-permeable mechanosensitive channels (MSCs) belonging to the Piezo and TRP channel families, blocks cation-selective stretch-activated channels (SACs), and attenuates lysophosphatidylcholine (LPC)-induced astrocyte toxicity and microglia reactivity. toxicity and microglia reactivity.D-GsMTx4 TFA prevented myocardial infarction in a mouse model of ischemia/reperfusion and can be used to characterize the role of excitatory MSCs in normal physiology and pathology.
  • $438
In Stock
Size
QTY
TargetMol | Inhibitor Hot
SN50
T12942213546-53-3
SN50 is a cell permeable NF-κB translocation inhibitor.
  • $88
In Stock
Size
QTY
Phoenixin-14
PNX-14
T804221415039-79-0
Phoenixin-14 (PNX-14), an active endogenous isoform, induces an anxiolytic effect by activating the AHA GnRH system in mice and protects against ischemia reperfusion-induced cytotoxicity in microglia [1] [2].
  • Inquiry Price
Size
QTY
PapRIV TFA
T83734
PapRIV, a quorum-sensing heptapeptide derived from B. cereus, undergoes synthesis as a 48-amino acid polypeptide. This compound is secreted and then extracellularly processed by NprB proteases into its active form. At concentrations ranging from 1-25 µM, PapRIV triggers the production of IL-6 and TNF-α, as well as NF-κB translocation, specifically in BV-2 microglia cells.
  • $55
Backorder
Size
QTY